Skip to content

The Diagnosis and Treatment System of Transesophageal Echocardiography in ICU

The Diagnosis and Treatment System of Transesophageal Echocardiography in ICU

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03811730
Enrollment
200
Registered
2019-01-22
Start date
2019-03-01
Completion date
2023-09-30
Last updated
2021-07-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Critically Ill

Keywords

transesophageal echocardiography, intensive care unit

Brief summary

Transesophageal ultrasound offers imaging through the esophagus on the surface of the heart, with good image quality and unique advantages. However, no studies to date have examined its effect in critically ill patients in China.Therefore, the investigators aimed to compare the efficacy and safety of TEE with TTE. the investigators will conducte a Multi-center, prospective observational control study enrolling critically ill adult patients in several ICU in China .

Detailed description

Patients in ICU were assessed for the need for TEE by trained researcher. Eligible patients would be conducted tee examination by researcher A, TTE by the researcher B ,at the same time, researcher C records the basic condition and clinical data of patientsand carried out micro-enlargement test.The examination results are judged by A and B respectively and provided to the physician of this patient, and A return visit to the physician wold be conducted by researcher D to evaluate the acceptance of TTE and TEE results and judge the clinical effects. The primary outcome is the clinical effects.

Interventions

DIAGNOSTIC_TESTTransesophageal echocardiography

Eligible patients would be conducted both Transesophageal echocardiography and Transthoracic echocardiography to offer independent results

Sponsors

Kang Yan
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SCREENING
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. The quality of Transthoracic echocardiography is poor ( \>3 sections cannot be obtained or the inner membrane is not clear) 2. The diagnosis of the etiology by Transthoracic ultrasonography is still unclear 3. The results of Transthoracic ultrasonography are inconsistent with clinical judgment or cannot explain the existing signs. 4. No obvious improvement or even aggravation after thoracic examination and corresponding treatment 5. Special conditions or clinical scenarios 6. Other clinicians think a TEE check is required.

Exclusion criteria

1. There is a tee test taboo and clinicians evaluate the risk over benefit 2. Did not sign an informed consent form

Design outcomes

Primary

MeasureTime frameDescription
Conclusion of the adoption48 hours after completion of the examinationResearcher C conducted a questionnaire survey on attending physician to evaluate the effect

Secondary

MeasureTime frameDescription
adverse eventscompletion of the examinationAdverse events associated with the examination,eg.1.Anesthetic allergy;2.Nausea, vomiting, choking cough or aspiration;3.Laryngeal edema and even asphyxiation;4.Severe arrhythmia;5.Esophageal perforation, bleeding, or local hematoma;6.Other accidental deaths, such as acute myocardial infarction, shock, haemorrhage and possibly even death;7.Other unpredictable contingencies or complications

Countries

China

Contacts

Primary ContactYi Li, PhD
526563716@qq.com(+86)13438168612

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026